Green Tomato
VC Fund
Kwun Tong, Hong Kong
Green Tomato is a VC fund in Kwun Tong focused on Medical and Health Care. GT Group specializes in mobile enterprise solutions, startup accelerator and mobile innovation powerhouse.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Green Tomato invests in
Stages Green Tomato invests in
Countries Green Tomato invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Benny Leung
|
|||
Stephen Wong
|
|||
Sunny Kok
|
|||
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Series B 1 (33%)
- Funding Round 1 (33%)
- Venture - Series Unknown 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Benny Leung
Chief Operating Officer
|
Chief Operating Officer | Total investments: 0 | Find email | |
|
Stephen Wong
Chief Technology Officer
|
Chief Technology Officer | Total investments: 0 | Find email | |
|
Sunny Kok
Founder and CEO
|
Founder and CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology.The company is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, formed in2009. It is headquartered in the Shanghai Caohejing High-Technology Park. | $156M / Venture - Series Unknown / Jul 20, 2018 | ||
| Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology.The company is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, formed in2009. It is headquartered in the Shanghai Caohejing High-Technology Park. | $190M / Series B / Dec 22, 2017 | ||
| See all 3 investments → | |||
Co-Investors
Fosun Pharma
2 deals together
ShenZhen GTJA Investment Group
2 deals together
CICC
1 deal together
Loyal Valley Capital
1 deal together
New China Capital Management
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Green Tomato invest in?
Green Tomato invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Green Tomato?
Public channels for Green Tomato include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Green Tomato?
The team at Green Tomato includes Benny Leung (Chief Operating Officer), Stephen Wong (Chief Technology Officer) and Sunny Kok (Founder and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
